I think we can take it as a given today that a sole-source vendor, given an opportunity, is going to stick it to its customers and then some:
The cost of saving your child’s life has gotten a lot more expensive.
Parents getting ready for back to school season have another item to toss in the basket along with Trapper Keepers and boxes of pencils and they’re facing sticker shock at the latest price increase.
Doctors and patients say the Mylan pharmaceutical company has jacked up the prices for an EpiPen — the portable device that can stop a potentially life-threatening allergic reaction — from around $100 in 2008 to $500 and up today.
That’s a hike of over 400 percent.
And it’s not because the drug itself is so gosh-darn expensive, either:
The wholesale cost in the developing world is between US$0.10 and US$0.95 a vial.
I tell you what, that little injector gizmo containing a buck’s worth of medicine had better be able to survive a freaking zombie apocalypse.